Chase Investment Counsel Corp Mckesson Corp Transaction History

Chase Investment Counsel Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 19, 2024	SELL	$518.81 - $607.81 $119,326 - $139,796	-230 Reduced 2.5%	8,985 $5.25 Million
Q2 2024 Aug 02, 2024	BUY	$518.81 - $607.81 $1.69 Million - $1.98 Million	3,257 Added 54.67%	9,215 $5.38 Million
Q1 2024 May 02, 2024	SELL	$473.42 - $539.26 $2,840 - $3,235	-6 Reduced 0.1%	5,958 $3.2 Million
Q4 2023 Feb 05, 2024	BUY	$437.42 - $470.64 $222,646 - $239,555	509 Added 9.33%	5,964 $2.76 Million
Q3 2023 Nov 08, 2023	BUY	$402.4 - $446.42 $2.2 Million - $2.44 Million	5,455 New	5,455 $2.37 Million

1,713

112M

871K

900K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $75.6B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

Stay updated on Chase Investment Counsel Corp with notifications on news.